AIDS News and Research

RSS

Fewer teens getting pregnant and more using condoms

According to a new report by the Federal Interagency Forum on Child and Family Statistics, in 2005 the teenage birth rate in the U.S. reached an all time low and more high school students were using condoms.

16 Jul 2007

Resource pack helps disabled children speak out

At present, many disabled children, particularly those children with limited vocal language, are excluded from being involved in decision-making processes in schools. Thanks to the launch of a new resource pack for teachers this Friday [July 13] children with little or no speech could soon be communicating their views.

12 Jul 2007

Simple interventions may increase prostate cancer screening

Prostate cancer is the most common cancer in American men, with an estimated incidence of 234,460 cases and 27,360 deaths in 2006. Screening for prostate cancer remains controversial due to insufficient evidence to recommend for or against screening.

12 Jul 2007

Senate Health Committee votes to repeal written informed consent in HIV testing bill (AB 682), notes AHF

AIDS Healthcare Foundation (AHF), the US' largest provider of HIV/AIDS healthcare, prevention and education, and operator of the largest non-government HIV testing program in California which conducts more than 15,000 HIV tests annually, has lauded the California State Senate Health Committee for its vote in favor of Assembly Bill 682, California's Routine HIV Screening Bill, which will now move on to the Senate Appropriations Committee.

12 Jul 2007

Larger HIV prevention programs are cheaper

A UCSF-led team of researchers has found that larger HIV prevention programs in low and middle-income countries can increase efficiency and cause program unit costs to plummet. HIV prevention programs in Uganda, South Africa, Mexico, Russia and India were examined.

12 Jul 2007

Calypte announces India approval for HIV test

Calypte Biomedical Corporation has announced that it has received registration and marketing approval for its Aware HIV-1/2 OMT (oral fluid) rapid test in India from the Central Drugs Standard Control Organisation, commonly referred to as the Drug Control Authority of India ("DCAI").

12 Jul 2007

Confronting myths and myopia on the road from Doha

A Penn State researcher argues that ambiguous international rules outlining when and how governments may "break" pharmaceutical patents may end up significantly reducing incentives for innovation while at the same time failing to increase access to medicines.

11 Jul 2007

Kaposi sarcoma tumors arise independently from multiple cells

Kaposi sarcoma is unique among cancers because most tumors grow from a small number of different cells, whereas nearly all other cancers arise from a single cell, according to a study published online July 10 in the Journal of the National Cancer Institute.

11 Jul 2007

International AIDS Society releases Sydney declaration, calls for increase in research funding to fight HIV/AIDS

The International AIDS Society on Tuesday ahead of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention -- scheduled to take place July 22 to July 25 in Sydney, Australia -- released the Sydney Declaration, which calls for increased research funding to fight HIV/AIDS worldwide, the Australian Associated Press reports.

11 Jul 2007

China should provide country's 140,000 AIDS orphans with HIV/AIDS information, financial assistance, UNICEF says

There are an estimated 140,000 children in China who have lost one or both parents to AIDS-related illnesses, according to figures released Sunday by UNICEF China, the South China Morning Post reports.

11 Jul 2007

Malawi aims to provide 150,000 HIV-positive people with access to antiretrovirals

Malawi plans to provide 150,000 HIV-positive people with access to no-cost antiretroviral drugs by the end of the year, Biziwick Mwale, chief of the National AIDS Commission, said on Monday, AFP/Sunday Times reports.

11 Jul 2007

Development banks not fulfilling health pledges

Multilateral development banks are not fulfilling their commitments to support initiatives involving reproductive and sexual health in developing countries, according to a new study released by Gender Action, a Washington, D.C.-based organization that monitors the banks' policies on women and gender equality, Inter Press Service reports.

11 Jul 2007

Vietnamese aims to increase access to HIV care, treatment

The Vietnamese government has issued a series of documents aimed at increasing access to HIV/AIDS care and treatment in the country in an effort to keep the country's HIV prevalence below 0.27% in 2007, the Vietnam News Agency reports.

11 Jul 2007

U.S. trial of new microbicide for HIV prevention to be tested in young women

Nearly half of all people infected with HIV/AIDS are now women, the majority of whom contracted the disease through sexual intercourse with male partners.

10 Jul 2007

Syphilis cases spike in New York City

After leveling off for more than two years, and declining in 2006, new syphilis cases spiked in New York City during the first three months of 2007.

10 Jul 2007

Calypte begins U.S. initiative

Calypte Biomedical Corporation has announced that it has leased an 11,000+ square foot site located in Portland, Oregon.

10 Jul 2007

Women's HIV/AIDS conference delegates develop action plan to foster women's, girls' leadership in fight against disease

Delegates on Saturday at the close of the first International Women's Summit on Women's Leadership and HIV and AIDS in Nairobi, Kenya, released a 10-point action plan that aims to foster leadership roles of women and girls in the fight against HIV/AIDS, the Nation/AllAfrica.com reports.

10 Jul 2007

El Salvador needs to take increased HIV/AIDS control efforts

Although health officials in El Salvador have launched an HIV testing campaign in the country, some advocates say that the country needs to take increased efforts to control the growing number of HIV cases in the country, Inter Press Service reports.

10 Jul 2007

Etravirine reduces HIV viral loads when taken with Prezista

The experimental antiretroviral drug etravirine, made by Johnson & Johnson subsidiary Tibotec Pharmaceuticals, greatly reduces HIV viral loads in people with a history of drug resistance when taken in combination with Tibotec's antiretroviral Prezista, according to two studies published Saturday in the journal The Lancet.

10 Jul 2007

U.S. NIH funded trial of VivaGel in sexually active young women commences

Starpharma Holdings Limited today announced the commencement in the U.S. of a trial to assess the safety and acceptability of SPL7013 Gel (VivaGel) in sexually active young women.

9 Jul 2007